Philip W. Hinds

14.5k total citations · 6 hit papers
107 papers, 11.8k citations indexed

About

Philip W. Hinds is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Philip W. Hinds has authored 107 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 66 papers in Oncology and 20 papers in Cell Biology. Recurrent topics in Philip W. Hinds's work include Cancer-related Molecular Pathways (61 papers), Ubiquitin and proteasome pathways (18 papers) and Ocular Oncology and Treatments (16 papers). Philip W. Hinds is often cited by papers focused on Cancer-related Molecular Pathways (61 papers), Ubiquitin and proteasome pathways (18 papers) and Ocular Oncology and Treatments (16 papers). Philip W. Hinds collaborates with scholars based in United States, Australia and Japan. Philip W. Hinds's co-authors include Cathy A. Finlay, Arnold J. Levine, Robert A. Weinberg, Andrew Arnold, Steven I. Reed, Steven F. Dowdy, Tse‐Hua Tan, Moshe Oren, Daniel Eliyahu and Sibylle Mittnacht and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Philip W. Hinds

106 papers receiving 11.5k citations

Hit Papers

The p53 proto-oncogene can act as a suppressor of transfo... 1988 2026 2000 2013 1989 1988 1992 1993 1989 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The p53 proto-oncogene can act as a suppressor of transformation
    1989 1.6k citations Cathy A. Finlay, Philip W. Hinds et al. profile →
  2. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    1988 1.0k citations Cathy A. Finlay, Philip W. Hinds et al. Molecular and Cellular Biology profile →
  3. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
    1992 899 citations Philip W. Hinds et al. profile →
  4. Physical interaction of the retinoblastoma protein with human D cyclins
    1993 666 citations Philip W. Hinds et al. profile →
  5. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
    1989 499 citations Philip W. Hinds, Cathy A. Finlay et al. profile →
  6. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
    2000 442 citations Philip W. Hinds et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip W. Hinds United States 47 7.2k 7.2k 2.0k 1.4k 1.4k 107 11.8k
Michael A. Tainsky United States 47 5.2k 0.7× 7.8k 1.1× 2.5k 1.3× 1.9k 1.3× 1.0k 0.7× 156 12.5k
Andrew Koff United States 53 8.7k 1.2× 10.2k 1.4× 2.0k 1.0× 1.2k 0.8× 755 0.5× 103 15.0k
Jiřina Bártková Denmark 62 7.8k 1.1× 10.5k 1.5× 2.8k 1.4× 1.8k 1.2× 760 0.5× 136 15.4k
Denise Crowley United States 37 5.5k 0.8× 8.8k 1.2× 3.5k 1.8× 1.0k 0.7× 908 0.7× 48 14.0k
Annie Yang United States 34 7.5k 1.0× 8.4k 1.2× 1.4k 0.7× 1.1k 0.8× 2.5k 1.8× 53 12.4k
Takashi Tokino Japan 62 6.5k 0.9× 12.8k 1.8× 3.8k 1.9× 1.7k 1.2× 1.1k 0.8× 227 17.4k
Gordon Peters United Kingdom 48 4.8k 0.7× 7.2k 1.0× 1.8k 0.9× 1.1k 0.7× 544 0.4× 95 10.4k
Mark E. Ewen United States 38 6.7k 0.9× 7.1k 1.0× 1.1k 0.6× 1.9k 1.3× 554 0.4× 54 10.4k
Marion M. Nau United States 43 4.2k 0.6× 6.0k 0.8× 1.7k 0.9× 1.1k 0.8× 586 0.4× 75 9.2k
James DeGregori United States 59 5.1k 0.7× 8.2k 1.1× 2.2k 1.1× 1.4k 1.0× 408 0.3× 172 12.0k

Countries citing papers authored by Philip W. Hinds

Since Specialization
Citations

This map shows the geographic impact of Philip W. Hinds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip W. Hinds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip W. Hinds more than expected).

Fields of papers citing papers by Philip W. Hinds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip W. Hinds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip W. Hinds. The network helps show where Philip W. Hinds may publish in the future.

Co-authorship network of co-authors of Philip W. Hinds

This figure shows the co-authorship network connecting the top 25 collaborators of Philip W. Hinds. A scholar is included among the top collaborators of Philip W. Hinds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip W. Hinds. Philip W. Hinds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bayer, Abraham, et al.. (2024). Deletion of MyD88 in T Cells Improves Antitumor Activity in Melanoma. American Journal Of Pathology. 194(6). 1007–1019. 2 indexed citations
2.
Liu, Fengming, Shirui Hou, Jamy C. Peng, et al.. (2022). A kinase-independent function of cyclin-dependent kinase 6 promotes outer radial glia expansion and neocortical folding. Proceedings of the National Academy of Sciences. 119(38). e2206147119–e2206147119. 6 indexed citations
3.
Kottakis, Filippos, Parthena Foltopoulou, Ioannis Sanidas, et al.. (2014). NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells. Cancer Research. 74(14). 3935–3946. 68 indexed citations
4.
Luo, Chi, Jinghao Sheng, Miaofen G. Hu, et al.. (2013). Loss of ARF Sensitizes Transgenic BRAFV600E Mice to UV-Induced Melanoma via Suppression of XPC. Cancer Research. 73(14). 4337–4348. 25 indexed citations
5.
Brown, Nelson E., Rinath Jeselsohn, Teeru Bihani, et al.. (2012). Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium. Cancer Research. 72(24). 6477–6489. 59 indexed citations
6.
Huang, Mingqian, Cyrille Sage, Yong Tang, et al.. (2011). Overlapping and distinct pRb pathways in the mammalian auditory and vestibular organs. Cell Cycle. 10(2). 337–351. 30 indexed citations
7.
Jeselsohn, Rinath, Nelson E. Brown, Lisa M. Arendt, et al.. (2010). Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis. Cancer Cell. 17(1). 65–76. 105 indexed citations
8.
Hu, Miaofen G., Amit Deshpande, Miriam Enos, et al.. (2009). A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis. Cancer Research. 69(3). 810–818. 96 indexed citations
9.
Piscopo, Denise M. & Philip W. Hinds. (2008). A Role for the Cyclin Box in the Ubiquitin-Mediated Degradation of Cyclin G1. Cancer Research. 68(14). 5581–5590. 18 indexed citations
10.
Wang, Yang, Subir K. Ray, Philip W. Hinds, & Andrew B. Leiter. (2007). The retinoblastoma protein, RB, is required for gastrointestinal endocrine cells to exit the cell cycle, but not for hormone expression. Developmental Biology. 311(2). 478–486. 5 indexed citations
11.
Deshpande, Amit & Philip W. Hinds. (2006). The Retinoblastoma Protein in Osteoblast Differentiation and Osteosarcoma. Current Molecular Medicine. 6(7). 809–817. 24 indexed citations
12.
Sage, Cyrille, Mingqian Huang, Gabriel M. Gutierrez, et al.. (2005). Proliferation of Functional Hair Cells in Vivo in the Absence of the Retinoblastoma Protein. Science. 307(5712). 1114–1118. 208 indexed citations
13.
Marsit, Carmen J., Shichun Zheng, Kenneth Aldape, et al.. (2005). PTEN expression in non–small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Human Pathology. 36(7). 768–776. 201 indexed citations
14.
Hinds, Philip W.. (2003). Cdk2 dethroned as master of S phase entry. Cancer Cell. 3(4). 305–307. 29 indexed citations
15.
Yang, Hai-Su & Philip W. Hinds. (2003). Increased Ezrin Expression and Activation by CDK5 Coincident with Acquisition of the Senescent Phenotype. Molecular Cell. 12(1). 269–270. 4 indexed citations
16.
17.
Thomas, David M., Shannon A. Carty, Denise M. Piscopo, et al.. (2001). The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic Differentiation. Molecular Cell. 8(2). 303–316. 303 indexed citations
18.
Grossel, Martha J., et al.. (1999). A yeast two-hybrid system for discerning differential interactions using multiple baits. Nature Biotechnology. 17(12). 1232–1233. 14 indexed citations
19.
Finlay, Cathy A., Philip W. Hinds, Tse‐Hua Tan, et al.. (1988). Activating Mutations for Transformation by p53 Produce a Gene Product That Forms an hsc70-p53 Complex with an Altered Half-Life. Molecular and Cellular Biology. 8(2). 531–539. 283 indexed citations
20.
Hinds, Philip W. & R. D. Blake. (1985). Delineation of Coding Areas in DNA Sequences Through Assignment of Codon Probabilities. Journal of Biomolecular Structure and Dynamics. 3(3). 543–549. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Tainsky Breakdown of academic impact, for papers by Andrew Koff Breakdown of academic impact, for papers by Jiřina Bártková Breakdown of academic impact, for papers by Denise Crowley Breakdown of academic impact, for papers by Annie Yang Breakdown of academic impact, for papers by Takashi Tokino Breakdown of academic impact, for papers by Gordon Peters Breakdown of academic impact, for papers by Mark E. Ewen Breakdown of academic impact, for papers by Marion M. Nau Breakdown of academic impact, for papers by James DeGregori
Rankless by CCL
2026